All these new targets are very exciting. With this many kicks on goal we have to have at least one succeed. As an aside I do like the communication style of the company. We really are kept in the loop on what is going on and what is next.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%